Related Experiment Video
Updated: Apr 18, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
[Isoflurane-induced malignant hyperthermia during intensive-care treatment]
B Wendlandt1, S Turinsky, M Schmitz
1Klinik für Anästhesie, operative Intensivmedizin und Schmerztherapie, Helios St. Johannes Klinik Duisburg, An der Abtei 7-11, 47166, Duisburg, Deutschland.
Abstract:
Malignant hyperthermia (MH), an inherited myopathia varying in severity and course, is induced by halogenated anesthetic agents and depolarizing muscle relaxants. First recognized as a distinct disease entity in 1960, MH is defined as an anesthesia-related disease due to the agents by which it is triggered. Given the wide use of these preparations in prehospital emergency medicine and intensive care treatment, physicians in other disciplines may also encounter MH.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
Related Concept Videos
Increased Body Temperature
Inhalational Anesthetics: Overview
Types of Fever
Here are the different types of fever:
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Acute Respiratory Failure-III
Homeostatic Imbalances in Body Temperature